Korean J Pediatr.
2019 Apr;62(4):119-123. 10.3345/kjp.2019.00150.
Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
- Affiliations
-
- 1Department of Pediatrics, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea. msped@yahoo.com
- KMID: 2451947
- DOI: http://doi.org/10.3345/kjp.2019.00150
Abstract
- Kawasaki disease (KD) is a systemic vasculitis that mainly affects younger children. Intravenous immunoglobulin (IVIG) resistant cases are at increasing risk for coronary artery complications. The strategy on prediction of potential nonresponders and treatment of IVIG-resistant patients is now controversial. In this review the definition and predictors of IVIG-resistant KD and current evidence to guide management are discussed.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy of Dexamethasone Therapy for Coronary Lesion after Immunoglobulin-retreated Kawasaki Disease
- The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
- Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease
- A Comparison of Concentrations of TNF-alpha and IFN-gamma between the Dose of Intravenous Immunoglobulin 1 gm/kg and 2 gm/kg in the Patients with Kawasaki Disease
- Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
